Literature DB >> 19850706

Role and clinical course of verotoxigenic Escherichia coli infections in childhood acute diarrhoea in Argentina.

Mariana Alejandra Rivero1,2, Juan Antonio Passucci1, Edgardo Mario Rodriguez1, Alberto Ernesto Parma2.   

Abstract

The aim of this study was to investigate the role and clinical course of verotoxigenic Escherichia coli (VTEC) infections in children with acute diarrhoea from Argentina, the country with the highest worldwide incidence of haemolytic uraemic syndrome (HUS). To accomplish this objective, 437 samples from children up to 6 years old with acute diarrhoea were collected and processed. More than 60 % of the children studied presented watery or mucous diarrhoea without blood, and in 25.2 % of the cases the samples contained blood. In a first screening, a multiplex PCR was performed to detect the presence of the vt(1), vt(2), eae, ehxA and saa virulence genes. The strains were then isolated and analysed to characterize their serotypes, virulence genes, antibiotic susceptibility profiles and verotoxin (VT) production. Forty-four of the 437 samples (10.1 %) were positive for VTEC virulence genes. VTEC-infected patients presented different types of diarrhoea (27.3 % belonged to the non-bloody type). Several serotypes and virulence genotypes were found. Isolates belonged to the serotypes O157 : H7, O145 : H(-), O26 : H11, O121 : H19, O111 : H2 and O118 : H2. HUS developed in 16 (36.4 %) patients positive for VTEC virulence genes. All of the VTEC isolates produced a cytopathic effect on Vero cell monolayers, confirming the ability to express VT. Despite most strains being sensitive to all of the antimicrobials studied, a positive association between clinical progression to HUS and antibiotic therapy was observed for the total number of patients studied, as well as for the VTEC(+) group. In conclusion, the data obtained in this study increase our knowledge of the role and clinical course of VTEC infection in childhood acute diarrhoea beyond bloody diarrhoea, and might be considered for the prevention, diagnosis and management of this disease. It is possible that the optimal approach for VTEC diagnosis could be using multiplex PCR to search for the presence of the vt(1), vt(2), eae and ehxA genes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19850706     DOI: 10.1099/jmm.0.015560-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  25 in total

1.  Seasonal variation of HUS occurrence and VTEC infection in children with acute diarrhoea from Argentina.

Authors:  M A Rivero; J A Passucci; E M Rodríguez; A E Parma
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-22       Impact factor: 3.267

Review 2.  Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis.

Authors:  Stephen B Freedman; Jianling Xie; Madisen S Neufeld; William L Hamilton; Lisa Hartling; Phillip I Tarr; Alberto Nettel-Aguirre; Anderson Chuck; Bonita Lee; David Johnson; Gillian Currie; James Talbot; Jason Jiang; Jim Dickinson; Jim Kellner; Judy MacDonald; Larry Svenson; Linda Chui; Marie Louie; Martin Lavoie; Mohamed Eltorki; Otto Vanderkooi; Raymond Tellier; Samina Ali; Steven Drews; Tim Graham; Xiao-Li Pang
Journal:  Clin Infect Dis       Date:  2016-02-24       Impact factor: 9.079

3.  Influence of RNase E deficiency on the production of stx2-bearing phages and Shiga toxin in an RNase E-inducible strain of enterohaemorrhagic Escherichia coli (EHEC) O157:H7.

Authors:  Thujitha Thuraisamy; Patricia B Lodato
Journal:  J Med Microbiol       Date:  2018-04-05       Impact factor: 2.472

4.  Antibiogram of E. coli serotypes isolated from children aged under five with acute diarrhea in Bahir Dar town.

Authors:  Ayrikim Adugna; Mulugeta Kibret; Bayeh Abera; Endalkachew Nibret; Melaku Adal
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

5.  Predicting the presence of non-O157 Shiga toxin-producing Escherichia coli in ground beef by using molecular tests for Shiga toxins, intimin, and O serogroups.

Authors:  Joseph M Bosilevac; Mohammad Koohmaraie
Journal:  Appl Environ Microbiol       Date:  2012-07-27       Impact factor: 4.792

6.  Lipopolysaccharide as an antigen target for the formulation of a universal vaccine against Escherichia coli O111 strains.

Authors:  Maurílio F Santos; Roger R C New; Gabrielle R Andrade; Christiane Y Ozaki; Osvaldo A Sant'Anna; Lucia Mendonça-Previato; Luis R Trabulsi; Marta O Domingos
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

7.  Genetic Diversity of the fliC Genes Encoding the Flagellar Antigen H19 of Escherichia coli and Application to the Specific Identification of Enterohemorrhagic E. coli O121:H19.

Authors:  Lothar Beutin; Sabine Delannoy; Patrick Fach
Journal:  Appl Environ Microbiol       Date:  2015-04-10       Impact factor: 4.792

8.  Prevalence and characterization of non-O157 shiga toxin-producing Escherichia coli isolates from commercial ground beef in the United States.

Authors:  Joseph M Bosilevac; Mohammad Koohmaraie
Journal:  Appl Environ Microbiol       Date:  2011-01-21       Impact factor: 4.792

9.  Incidence and virulence determinants of verocytotoxin-producing Escherichia coli infections in the Brussels-Capital Region, Belgium, in 2008-2010.

Authors:  Glenn Buvens; Yves De Gheldre; Anne Dediste; Anne-Isabelle de Moreau; Georges Mascart; Anne Simon; Daniël Allemeersch; Flemming Scheutz; Sabine Lauwers; Denis Piérard
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

Review 10.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.